However, pediatric COVID-19 patients usually exhibit higher IFN-α levels due to enhanced expression of RIG-I, MDA5, and toll-like receptors (TLRs 2/3/4/7/8) in the respiratory tract to trigger a robust and early antiviral response (Thorne et al., 2021). The gene discussed is IFNA1; the disease is COVID-19.